13.02.2019
Extraordinary Board Meeting No.1 2017
Extraordinary Board Meeting No.1 2017 July 3rd 2017
13.02.2019
Board Meeting No 2. 2017
Board Meeting No. 2 2017 June 27th 2017
23.01.2019
Protocol Extraordinary Annual Meeting January 23rd 2019
 
23.01.2019
Board Meeting No. 1 2019
Board Meeting No. 1 2019 January 23rd 2019
19.12.2018
EPO patent granted December 19th 2018
Granted EPO (European Patent Office) patent in wound healing.
10.12.2018
Eqology AS launch Collagen Booster Serum
 An important commercial milestone has been reached for Regenics December 10th with the launch of the ground breaking EQ Collagen Boosting Serum from the Norwegian Direct Selling Company Eqology AS.  
30.11.2018
Protocol from Extraordinary Annual Meeting September 26th 2018
September 26th 2018 Protocoll of Extraordinary Annual Meeting September 26th 2018. The Annual Meeting 2017 took place in the Companys office, Karvesvingen. 2, Oslo
29.11.2018
Notification of grant:Divisional EPO patent
Notification of grant: Divisional EPO patent
27.11.2018
Adam Robertson new Chief Scientific Officer in Regenics
 Adam Robertson has today signed up as  Chief Scientific Officer for Regenics AS.  Adam is part of the team that develops cutting  edge skin care and wound healing at Regenics.  Adam...
07.11.2018
Board Meeting No. 4 2018
Regenics Board Meeting No. 4 2018 November 7th 2018
17.09.2018
Bernat Rocarols - New Business Developer Regenics
   
04.09.2018
Board Meeting No. 3 2018
Regenics Board Meeting No. 3 2018 September 4th 2018
28.06.2018
Protocol Annual Meeting 2018
June 28th 2018 Protocoll of Regenics Annual Meeting on June 28th 2018. The Annual Meeting 2018 took place in the Companys office, Karvesvingen. 2, Oslo
15.06.2018
Upcoming event: 37C Health Meeting Stavanger
Regenics AS attends the 37C "Digitalization in Health" meeting on June 19-20 of June 2018 at Forus Stavanger. CEO Henrik Lund, co-chairs the meeting    
13.06.2018
Regenics AS Annual Report 2017
Regenics post a small positive 2017 result with topline in excess of 0.047 mill NOK. 
13.06.2018
Board Meeting No. 2 2018
Regenics Board Meeting No. 2 2018 June 13th  2018

Page 1 of 6   >  >>

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.